MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-024-16650-6

Медицинская библиотека · Annals of surgical oncology · 2024

Albumin-Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology.

Tadokoro Takeshi, Kobayashi Tsuyoshi, Honmyo Naruhiko, Kuroda Shintaro, Ohira Masahiro, Hashimoto Masakazu, Oishi Koichi, Oshita Akihiko, Abe Tomoyuki, Onoe Takashi, Kohashi Toshihiko, Ohdan Hideki

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

This study aimed to investigate the association between a new biomarker that incorporates albumin (Alb) and butyrylcholinesterase (BCHE) levels, as well as the prognosis of hepatocellular carcinoma (HCC) after hepatectomy.

METHODS

The study enrolled 1712 patients who underwent primary hepatectomy for HCC between January 2003 and December 2019 at seven institutions belonging to the Hiroshima Surgical Study Group of Clinical Oncology. The entire dataset was randomly split into discovery and validation cohorts in a 7:3 ratio. The product of the preoperative Alb and BCHE levels was defined as the ABC. In the discovery cohort, the patients in the high-ABC group (≥ 951) were compared with those in the low-ABC group (< 951). These findings then were confirmed in the validation cohort.

RESULTS

In the discovery cohort, a significant difference was observed in the 5-year survival rate between the high- and low-ABC groups (p < 0.001), and ABC was identified as an independent prognostic factor for HCC. Similarly, in the validation cohort, a significant difference was observed in the 5-year survival rate between the high- and low-ABC groups (p < 0.001), and ABC was identified as an independent prognostic factor for HCC. Furthermore, in the discovery and validation cohorts, significant differences in the early recurrence rate between the two groups were observed (p < 0.001 and p = 0.020, respectively).

CONCLUSIONS

For patients with HCC, ABC is a useful predictive biomarker because it can be calculated in a simple manner and because it provides accurate prognostic information.

Для цитирования: Tadokoro Takeshi, Kobayashi Tsuyoshi, Honmyo Naruhiko, Kuroda Shintaro, Ohira Masahiro, Hashimoto Masakazu, Oishi Koichi, Oshita Akihiko, Abe Tomoyuki, Onoe Takashi, Kohashi Toshihiko, Ohdan Hideki. Albumin-Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology.. Annals of surgical oncology. 2024. DOI: 10.1245/s10434-024-16650-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.